The Centers for Disease Control reported that in 2017 alone there were 80,000 flu-related deaths in the United States of America. For the last two decades, Americans have had the exact same options for influenza treatment. That reality is now changing, a new prescription tablet called Xofluza (baloxavir marboxil) will be available nationwide over the next several week.
The advantage to Xofluza is that it is only one tablet. Trials have shown that the new flu treatment reduces symptoms over approximately two days. Frequently reported side effects were diarrhea and bronchitis and did not occur any more frequently than those who received a placebo. It also reduced the oral and nasal viral level faster than Tamiflu. Further testing is planned to discover if Xofluza will be a better alternative to prevent the spread of the flu.
The Centers for Disease Control and Prevention recommends getting a flu shot by the end of October, but warns that while not perfect vaccines reduce your chance of getting, being hospitalized, or dying from the flu. Flu shots are usually available at pharmacies and your doctors office, among other locations.
Flu vaccines are covered under the 10 Essential Health Benefits required for all marketplace health insurance plans. Open enrollment for 2019 marketplace plans will be November 1-December 15, 2018 and American Exchange has a team of licensed agents ready to assist you! Give us a call at 1(888)995-1674 during open enrollment and we will help you find the best available plan for you.